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Abstract 
Saxifragifolin D (SD), a traditional Chinese medicine, is a pentacyclic triterpenoid compound first isolated from 
Androsace umbellata. Various plant triterpenoids have been reported to exhibit antitubercular activity. In this study, 
THP‑1‑derived macrophages were infected with an attenuated M. tuberculosis (M.tb) strain, H37Ra. Intracellular 
replication of M.tb was evaluated by counting the colonies after 4 weeks of incubation. The results indicated that 
SD treatment reduced the intracellular replication of M.tb in THP‑1‑derived macrophages but not in A549 cells. We 
performed a phagosome maturation test using confocal microscopy and found that SD treatment partially attenu‑
ated the phagosome arrest induced by M.tb infection. These effects were dependent on a VPS34‑associated pathway. 
Immunoprecipitation assays showed that SD increased intracellular UVRAG‑linked VPS34, the active VPS34 complex 
II. However, SD had no effect on the total VPS34 pool. Moreover, the results indicated that the SD‑mediated increase 
in VPS34 complex II activity was mediated by an AMPK‑dependent pathway. Collectively, these data indicate that SD 
may be a promising candidate for treatment of M.tb.
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Introduction
Tuberculosis(TB) continues to be a major threat to 
human health, with an estimated global mortality of 
1.43 million people each year (Maxmen 2013). The only 
approved vaccine, Bacille–Calmette–Guerin (BCG), 
an attenuated strain of Mycobacterium bovis, has been 
shown to protect children from severe TB but fails to 
block the transmission chain in adults. Mycobacterium 
tuberculosis (M.tb), is the causative agent of TB and can 
survive and replicate in macrophages. M.tb virulence 
is multifarious but initially relies on its ability to para-
sitize phagocytic cells and escape from the host immune 
system (Flannagan et  al. 2012). The major function of 
alveolar macrophages is uptake of inhaled microorgan-
isms through phagocytosis. This event depends on the 
formation of the phagosome, which then matures into a 
phagolysosome through a series of fusion reactions with 
lysosomes (Flannagan et al. 2012). In contrast to primary 
phagosomes, mature phagolysosomes contain antimi-
crobial peptides and hydrolases that are predominantly 
active under an acidic pH. Therefore, the maturation of 
the phagosome is crucial for alveolar macrophages to 
kill the captured microbes. M.tb is inhaled as an aerosol 
and phagocytosed by alveolar macrophages. Forty years 
ago, investigators reported that inhibition of phago-
some maturation was the major virulence mechanism of 
M.tb. Since then, numerous mechanisms underlying the 
disruption of phagosome maturation have been identi-
fied in M.tb infection (Russell 2011; Russell et al. 2013). 
Early work showed that M.tb predominantly blocked 
phagosome maturation by two small GTPases, Rab5 
and Rab7, in membrane trafficking and fusion on early 
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and late endosomes (Via et al. 1997). EEA1, the effector 
of Rab5, facilitates the delivery of Cathepsin D and the 
H+-ATPase subunit Vo from the trans-Golgi-network 
to the phagosome. This step is essential in phagosome 
maturation and acidification (Fratti et  al. 2003b). Later 
experiments revealed that the specific mechanism of 
phagosome maturation arrest is principally dependent 
on impairment of EEA1 recruitment, which is mediated 
by Rab5 and phosphatidylinositol 3-phosphate (PI3P) 
(Fratti et al. 2001). M.tb inhibits PIP3 production, which 
is responsible for the acquisition of lysosomal character-
istics (Chua and Deretic 2004). Recent studies identified 
several components of M.tb, such as ManLAM, which 
block phagosome maturation by reducing PI3P pro-
duction via inhibition of VPS34, a unique class III PI3K 
(Purdy et al. 2005).
Although treatment of drug-susceptible M.tb is effec-
tive, drug toxicity, reduced discovery of new drugs and 
increasing multi-drug resistance of M.tb indicate that 
new therapeutic strategies are needed (Zumla et  al. 
2013). As conventional pathogen-targeted strategies 
have the disadvantage of inducing microbial resistance, 
a new approach might focus on the modulation of host 
cellular immunity to improve pathogen eradication (Ejim 
et  al. 2011). Recently, researchers reported that AMPK 
activators controlled the intracellular growth of M.tb 
in macrophages. To date, studies have shown that the 
AMPK-associated signalling pathway is the major activa-
tor of VPS34 (Xu et al. 2016; Yang et al. 2014).
Saxifragifolin D (SD), a pentacyclic triterpenoid com-
pound, was first isolated from Androsace umbellate and 
is commonly used in the treatment of solid tumours in 
Chinese traditional medicine (Park et  al. 2010). Based 
on evidence showing that pentacyclic triterpenoids 
are novel activators of AMPK and may indirectly up-
regulate VPS34 (Akhtar et  al. 2016; Shi et  al. 2013), we 
determined whether the active ingredients of the Chinese 
herbal medicine SD could inhibit the intracellular growth 




SD (purity  >95%) was isolated from A. umbellate and 
dissolved in dimethyl sulfoxide (DMSO) at a concentra-
tion of 20 mM (Wang et  al. 2008). The attenuated M.tb 
strain (H37Ra) was purchased from China National Insti-
tution For bio-product and drag control. Human mono-
cytic THP-1 cells and A549 cells were purchased from 
the American Type Culture Collection (Manassas, VA, 
USA) and maintained in RPMI1640 containing 10% FBS 
and 1% penicillin/streptomycin mix. Rabbit anti-human 
VPS34 antibody (ab5451), rabbit anti-human UVRAG 
antibody (ab174550), rabbit anti-human AMPK antibody 
(ab131512) and phosphorylated AMPK (ab72845) anti-
bodies were purchased from Abcam (Cambridge, MA, 
USA). The internal reference beta-actin antibody and 
secondary antibodies, including horseradish peroxidase 
(HRP)-conjugated goat anti-rabbit IgG, were purchased 
from Zhongshan Goldenbridge Biotechnology (Peking, 
China).
Cell culture
The monocytic cell line THP-1 or A549 was maintained 
in RPMI 1640 supplemented with 10% foetal calf serum, 
2  mM  l-glutamine, 100  μg/ml streptomycin and 100 
U/ml penicillin. Cells were cultured in an incubator at 
37 °C with 5% CO2. Before treatments, THP-1 cells were 
seeded in 6-well culture dishes at a density of approxi-
mately 2  ×  106/ml in fresh medium. THP-1 cells were 
then stimulated with 20  ng/ml phorbol 12-myristate 
13-acetate (PMA, Sigma-Aldrich) for 1  day to induce 
macrophage-like cells.
Cell infection and bacterial enumeration
The attenuated M.tb strain (H37Ra) were used and cul-
tured in Proskauer and Beck (P and B) medium sup-
plemented with 0.05% Tween-80. For visualization of 
the phagocytosis of M.tb by THP-1 cells, 1 ml of H37Ra 
bacterial suspension (109/ml) was labelled by incubation 
with 0.5 mg FITC (Sigma) in 0.1 M carbonate buffer (pH 
9.0) at 37 °C for 2 h (Stokes et al. 1993). The bacterial sus-
pension was centrifuged and washed with PBS 3 times to 
remove unbound FITC. Before infection, the cells were 
cultured in 6-well plates and washed with RPMI1640 
3 times to remove serum and antibiotics. H37Ra bac-
teria were re-suspended and diluted in antibiotic-free 
RPMI1640 to infect THP-1-derived macrophages or 
A549 cells with a multiplicity of infection (MOI) of 5. The 
infected cells were maintained in an incubator at 37  °C 
with 5% CO2 for 2  h. The cells were then washed with 
PBS 3 times to remove the extracellular bacteria. Every 
48 h, the culture medium was replaced.
On days 0, 2, 4 and 6, the infected THP-1 or A549cells 
were lysed with1 ml 0.025% SDS to release the intracel-
lular M.tb. The lysate were then plated as serial dilutions 
on MB7H11 agar. Colonies were counted after 4 weeks of 
incubation at 37 °C, and the data are expressed as CFU/
ml.
Western blot analysis
The expression of the VPS34, UVRAG, AMPK and phos-
phorylated AMPK protein in each treatment group was 
detected by western blotting. Briefly cells were washed 
with ice-cold PBS 3 times and lysed on ice for 20  min 
with a western cell lysis buffer (Beyotime, Shanghai, 
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China) containing PMSF, protease inhibitors, and phos-
phatase inhibitors. The lysis products were then cen-
trifuged at 12,000 rpm for 15 min at 4  °C. Supernatants 
were standardized for equal protein concentration fol-
lowing the instructions of the BCA Protein Assay Kit 
(Beyotime, Shanghai, China). The samples were then 
mixed with loading buffer and boiled in water for 10 min. 
After separation by sodium dodecyl sulphate polyacryla-
mide gel electrophoresis (SDS-PAGE), the proteins were 
transferred onto polyvinylidene difluoride (PVDF) mem-
branes. The PVDF membranes were blocked in 5% (w/v) 
non-fat dried skim milk powder or 5% BSA (for detect-
ing phosphorylated AMPK)and incubated with diluted 
primary antibody (1:300 for VPS34, 1:1000 for UVRAG, 
1:800 for AMPK, 1:300 for phosphorylated AMPK, 1:200 
for beta-actin) overnight at room temperature. After the 
membranes were washed with PBST 3 times for 15 min, 
they were incubated with the secondary antibody, goat 
anti-rabbit IgG (HRP), at a 1:3000 dilution for 2 h. Blots 
were visualized using enhanced chemiluminescence fol-
lowing the protocol of the manufacturer of the reagent 
kit (KeyGen, Nanjing, China). The intensity of each band 
was measured using the Fluor-S MultiImager and Quan-
tityOne software (Bio-Rad, Hercules, CA, USA).
Co‑immunoprecipitation (Co‑IP)
Co-IP was performed following the instructions of 
the Co-Immunoprecipitation Kit (Thermo Scientific) 
(Peking, China). Generally, the cells were washed with 
PBS 3 times and lysed on ice for 30  min using IP lysis 
buffer (Beyotime) (Beijing, China) containing protease 
inhibitors (Thermo Scientific) (Peking, China). For 
removal of the nuclei and intact cells, the lysis prod-
ucts were centrifuged at 20,000×g for 15  min at 4  °C. 
Protein A agarose was washed and diluted by PBS. The 
diluted Protein A agarose (50%) was added to the pro-
tein at a 1:10 (v/v) ratio. The mixture was incubated on 
a 4  °C shaking table for 30 min and then centrifuged at 
20,000×g for 15  min at 4  °C to collect the supernatant. 
The supernatants were standardised at 5 μg/μl for equal 
protein concentration following the instructions in the 
Bicinchoninic Acid Protein Assay kit (Beyotime, Peking, 
China). Then, 5 μg rabbit anti-human VPS34 was added 
to an Eppendorf tube containing 200  μl protein and 
incubated on a 4  °C shaking table overnight. The anti-
gen–antibody complexes were captured by adding 100 μl 
Protein A agarose to the samples for 90 min at room tem-
perature. After centrifugation at 20,000×g for 1 min, the 
Protein A agarose containing the antigen–antibody com-
plexes was washed with ice-cold PBS 3 times. The pre-
cipitates were mixed with 5× western blot loading buffer 
and boiled for 5 min. After centrifugation at 20,000×g for 
15 min, the supernatants were prepared for SDS-PAGE.
Analysis of phagosome maturation by confocal microscopy
THP-1-derived macrophages were plated at a density 
of 2 × 105/ml in 12-well plates on a poly-l-lysine coated 
glass coverslip in each well. THP-1-derived macrophages 
were washed 3 times by PBS and infected with 1 × 106/ml 
FITC-labelled M.tb for 2 h at 37 °C. Cells were then washed 
3 times with RPMI1640 to remove extracellular bacteria. 
After 6 days of culture at 37 °C, the cells were incubated for 
20 min in RPMI1640 containing 70 nM LysoTracker Deep 
Red (ThermoFisher Scientific, ShangHai, China). Then, 
THP-1-derived macrophages were fixed with 4% para-
formaldehyde for 15 min. Slides were then visualized using 
a confocal microscope (TCS-SP5, Leica, Germany). Co-
localization was determined by identifying FITC-linked 
M.tb (Green) with over lapping LysoTracker(Red). Repre-
sentative images were obtained with a digital camera and 
were then processed using Adobe Photoshop 7.0.
Results
Cell viability assay
THP-1-derived macrophages or A549 cells were seeded 
in 96-well plates and exposed to different concentrations 
of SD (ranging from 2 to 10 μM) for 6 days. Cell viability 
was assessed by MTT assays. The result demonstrated a 
significant reduction of cell viability in cells cultured in 
8 μM SD for 6 days from both cell lines compared to that 
of the controls (Fig. 1).
SD decreases the intracellular replication of M.tb 
inTHP‑1‑derived macrophages but not A549 cells
Intracellular growth of M.tb was evaluated by counting the 
colonies after 4 weeks of incubation at 37 °C. A significant 
difference was observed in the growth of M.tb in THP-
1-derived macrophages treated by SD (6 μM) compared to 
that of the untreated THP-1-derived macrophages. Forty-
eight hours post-infection, the growth of intracellular M.tb 
was significantly inhibited by SD treatment compared to 
that of the negative control. Six days post-infection, the 
growth of intracellular M.tb in SD-treated THP-1-derived 
macrophages was only approximately half that of the con-
trol THP-1 cells (Fig. 2a). Given that M.tb can also infect 
alveolar epithelial cells, we performed similar investiga-
tions using A549 human type II alveolar epithelial cells. 
However, SD treatment did not affect the intracellular rep-
lication of M.tb in A549 cells (Fig. 2b).
SD increases phagosomal maturation in THP‑1‑derived 
macrophages during M.tb infection
Because SD could decrease M.tb replication in mac-
rophages, we next investigated the involvement of SD in 
phagosomal maturation by studying the co-localization 
of the FITC-labelled M.tb strain H37Ra with LysoTracker 
Red. We observed that only (21.4 ± 4.7)% of FITC-labelled 
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M.tb co-localized with LysoTracker-rich compartments in 
untreated THP-1-derived macrophages. However, signifi-
cantly more co-localization of M.tb and LysoTracker-rich 
compartments, (42.7  ±  6.5)%, was found in SD-treated 
THP-1 derived macrophages (Fig. 3).
Fig. 1 MTT assays for cell viability. THP‑1‑derived macrophages or 
A549 cells propagated in RPMI 1640 culture medium were used as 
negative controls. Cells were exposed to different concentrations of 
SD. Data are represented as the mean ± SD; n = 4, *P < 0.05 versus 
THP‑1controls; **P < 0.05 versus A549 controls
Fig. 2 Growth of M.tb in THP‑1‑derived macrophages (a) and A549 
cells (b). Results are expressed as CFU/ml. The data represent the 
average and the standard deviation obtained from 6 parallel inde‑
pendent infections. The experiment was repeated 4 times
Fig. 3 Confocal microscopy analysis of the co‑localization of M.tb 
and lysosomes. THP‑1‑derived macrophages were infected with 
FITC‑labelled M.tb (green) at an MOI of 5. After 6 days of culture at 
37 °C, the cells were treated with LysoTracker (red) for 20 min. The 
results are expressed as the percentage of co‑localization of M.tb and 
lysosome. (1) M.tb, M.tb‑infected macrophages were maintained in 
RPMI1640 culture medium for 6 days; (2) M.tb+SD(CTL), M.tb‑infected 
macrophages were maintained in RPMI1640 culture medium contain‑
ing DMSO (the solution medium of SD) for 6 days. DMSO was added 
to the culture medium at the same volume of SD; (3) M.tb+SD, M.tb‑
infected macrophages were maintained in RPMI1640 culture medium 
containing 6 μM SD for 6 days; (4) M.tb+SD+DOR(CTL), M.tb‑infected 
macrophages were maintained in RPMI1640 culture medium contain‑
ing 6 μM SD and the solution medium of dorsomorphin (DOR), 
DMSO, for 6 days. DMSO was added to the culture medium based on 
the volume of DOR; (5) M.tb+SD+DOR, M.tb‑infected macrophages 
were maintained in RPMI1640 culture medium containing 6 μM SD 
and 1 μM DOR for 6 days. Data are shown as the mean ± S.D. of 4 
independent experiments carried out in triplicate, with a minimum of 
50 phagosomes counted per experiment for each sample. *P < 0.05 
versus M.tb group; ★P < 0.05 versus M.tb+SD group. Colour figure 
online only
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SD increases the proportion of the VPS34/VPS15/
Beclin‑1/UVRAG tetramer in the VPS34 total pool in an 
AMPK‑dependent manner during M.tb infection
Because SD was a novel activator of AMPK and may 
indirectly activate VPS34, we assessed the formation of 
the VPS34/VPS15/Beclin-1/UVRAG tetramer, which 
is the active form in the VPS34 pool. As expected, M.tb 
infection did not influence the synthesis of VPS34 but 
decreased the UVRAG-linked VPS34 in THP-1-derived 
macrophages (Fig.  4a). SD treatments increased the 
UVRAG-linked VPS34 tetramers in M.tb-infected mac-
rophages but not total VPS34, indicating that SD did not 
influence the total VPS34 pool in macrophages.
To analyse the involvement of AMPK in the activa-
tion of VPS34 induced by SD, we further examined 
phosphorylated AMPK in M.tb-infected macrophages. 
Phosphorylated AMPK was significantly decreased by 
M.tb infection. In contrast, SD augmented AMPK phos-
phorylation in M.tb-infected macrophages. An AMPK 
specific inhibitor, dorsomorphin(DOR), could partially 
attenuate the up-regulation of p-AMPK induced by pre-
treatment of SD, indicating that an AMPK-dependent 
signalling pathway is involved in SD-induced VPS34 
activation in M.tb-infected THP-1-derived macrophages 
(Fig.  4b). To determine whether AMPK signalling was 
linked to enhanced phagosomal maturation following 
SD treatment, we performed fluorescence microscopy 
analyses. After 6  days of infection, M.tb was demon-
strated (42.7  ±  6.5)% co-localization with LysoTracker 
Red in SD-treated THP-1-derived macrophages, whereas 
M.tb was showed significantly less co-localization 
(30.9 ± 4.4%) with LysoTracker Red after DOR pretreat-
ment (Fig. 3). To demonstrate the involvement of AMPK 
signalling in the inhibition of M.tb replication in THP-
1-derived macrophages following SD treatment, we 
counted the M.tb colonies after 4 weeks of incubation at 
37  °C. The intracellular replication of M.tb was demon-
strated approximate 1.7-fold higher in M.tb+SD+DOR 
group than that in M.tb+SD group according to the M.tb 
colonies after 4 weeks of incubation at 37 °C (Fig. 5).
Discussion
A key factor of M.tb pathogenesis is its ability to sur-
vive in host macrophages. Phagosomes mature into 
phagolysosomes, as evidenced by a decrease in pH and 
increased activity of hydrolytic enzymes. However, the 
maturation of M.tb-containing phagosomes is arrested, 
and the bacteria survive within the host macrophage. 
M.tb resides within a novel vacuole that retains charac-
teristics of early endosomal compartments and fails to 
fuse with lysosomes (Russell 2003; Vergne et  al. 2004). 
Many researchers have focused on the disturbed proteins 
on M.tb-containing phagosomes to reveal the specific 
Fig. 4 Western blot analysis of VPS34 levels in THP‑1‑derived 
macrophages. a UVRAG‑linked VPS34 was detected by co‑IP. The 
results are shown as the relative UVRAG‑linked VPS34 normalized 
to total VPS34. b Phosphorylated AMPK was detected by western 
blot. Data are shown as the relative p‑AMPK levels normalized to 
total AMPK. (1) NT, THP‑1‑derived macrophages were maintained in 
RPMI1640 culture medium for 6 days; (2) M.tb, M.tb‑infected mac‑
rophages were maintained in RPMI1640 culture medium for 6 days; 
(3) M.tb+SD(CTL), M.tb‑infected macrophages were maintained in 
RPMI1640 culture medium containing DMSO(the solution medium 
of SD) for 6 days. DMSO was added to the culture medium at the 
same volume as SD; (4) M.tb+SD, M.tb‑infected macrophages were 
maintained in RPMI1640 culture medium containing 6 μM SD for 
6 days; (5) M.tb+SD+DOR(CTL), M.tb‑infected macrophages were 
maintained in RPMI1640 culture medium containing 6 μM SD and 
the solution medium of DOR(DMSO) for 6 days. The solute medium of 
DOR was added to the culture medium based on the volume of DOR; 
(6) M.tb+SD+DOR, M.tb‑infected macrophages were maintained in 
RPMI1640 culture medium containing 6 μM SD and 1 μM DOR for 
6 days. Data are shown as the mean ± S.D. of 4 independent experi‑
ments carried out in triplicate. *P < 0.05 versus NT group; ※P < 0.05 
versus M.tb group; ★P < 0.05 versus M.tb+SD group
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mechanisms of M.tb survival in macrophages. Early work 
showed that M.tb blocks phagosome maturation by Rab5 
and Rab7, two small GTPases associated with membrane 
trafficking in the fusion of the phagosome and lysosome 
(Via et  al. 1997). Later researchers identified a key step 
of phagosome fusion, the delivery of Cathepsin D and 
the H+-ATPase subunit Vo to the phagosome. This step 
is mediated by the recruitment of the Rab5 effector mol-
ecule EEA1. The recruitment of EEA1 to the membrane 
of the phagosome is highly dependent on the association 
of its FYVE domain with PI3P, which it is generated from 
PI by the PI3 kinase VPS34. Our data also demonstrated 
decreased activity of VPS34 in an M.tb-infected mac-
rophage mode (Fratti et al. 2003a).
SD is a pentacyclic triterpenoid compound isolated 
from A. umbellate. In previous reports, various types of 
plant triterpenoids have been reported to exhibit antitu-
bercular activity (Akihisa et  al. 2005; Jyoti et  al. 2015). 
However, few studies have focused on the intracellular 
inhibitory activity of triterpenoids in M.tb infection. In 
this study, we investigated the inhibitory activity of SD in 
M.tb-infected macrophages. Intracellular replication tests 
were performed after 4 weeks of incubation of M.tb with 
macrophage lysates. Different CFU numbers reflected 
different viabilities of intracellular M.tb in macrophages 
(Rampini et al. 2008). SD inhibited intracellular growth of 
M.tb 48  h post-infection as determined by the intracel-
lular replication test. Based on results showing that M.tb 
can also infect alveolar epithelial cells, we also treated 
M.tb-infected A549 cells with SD (Castro-Garza et  al. 
2012).We found that SD only suppressed the intracellu-
lar replication of M.tb in macrophages. This observation 
suggested that inhibition of intracellular bacteria might 
depend on a phagocytosis-related mechanism. As phago-
somal maturation arrest is one of the common features 
during M.tb infection, we then studied the influence of 
SD on phagosomal maturation arrest during M.tb infec-
tion. A mature phagosome has a pH of less than 5 (Rohde 
et  al. 2007). To visualize the mature phagosome during 
M.tb infection, we treated THP-1-derived macrophages 
with LysoTracker, which stained the compartments with 
a pH below 6 (von Bargen et al. 2009). The co-localization 
of M.tb and mature phagosomes increased approximately 
21% in SD-treated macrophages compared to that of the 
non-treated cells, indicating an increased phagocytic 
capacity following SD treatment.
VPS34, as a member of the phosphoinositide 3-kinase 
(PI3K) family of lipid kinases, is activated by forming a 
complex with a series of proteins. Most intracellular 
VPS34 forms a minimal complex, the VPS34–VPS15 
dimer. Current nomenclature refers to the tetramer con-
taining VPS34, VPS15, Beclin-1 and UVRAG (UV radia-
tion resistance-associated gene) as complex II, which 
is required for the membrane fusion of phagosomes 
and lysosomes (Lamb et  al. 2013). Over-expression of 
UVRAG and increased levels of the intracellular VPS34/
VPS15/Beclin-1/UVRAG complex resulted in increased 
lipid kinase activity (Sun et al. 2011; Zhong et al. 2009). 
Our immunoprecipitation assays showed that SD treat-
ment increased the proportion of VPS34/VPS15/Bec-
lin-1/UVRAG tetramers in the VPS34 pool. AMPK 
signalling is an important activator upstream of both the 
VPS34 complex I and complex II. AMPK phosphorylates 
VPS34 and Beclin1 and enhances the lipid kinase activ-
ity of the VPS34 tetramer (Xu et al. 2016). Based on our 
assays, the increased level of AMPK phosphorylation 
may be the probable mechanism of activation of VPS34 
tetramer induced by SD during M.tb infection. Therefore, 
SD promotes phagosomal maturation of macrophages 
during M.tb infection, and the specific mechanisms may 
be a pAMPK/VPS34 complex II-dependent cascade.
In this study, SD was shown to promote phagosome 
maturation and inhibit intracellular M.tb replication in 
THP-1-derived macrophages. The underlying mecha-
nism was highly related to the activation of VPS34 com-
plex II through an AMPK-dependent signalling cascade. 
These results suggest that a traditional Chinese herb may 
be used to treat infection of M.tb.
Fig. 5 Growth of M.tb in THP‑1‑derived macrophages. Results 
are expressed as CFU/ml. (1) M.tb, M.tb‑infected macrophages 
were maintained in RPMI1640 culture medium for 6 days; (2) 
M.tb+SD(CTL), M.tb‑infected macrophages were maintained in 
RPMI1640 culture medium containing DMSO (the solution medium 
of SD) for 6 days. DMSO was added to the culture medium at the 
same volume as SD; (3) M.tb+SD, M.tb‑infected macrophages were 
maintained in RPMI1640 culture medium containing 6 μM SD for 
6 days; (4) M.tb+SD+DOR(CTL), M.tb‑infected macrophages were 
maintained in RPMI1640 culture medium containing 6 μM SD and 
the solution medium of DOR(DMSO) for 6 days. The solute medium of 
DOR was added to the culture medium based on the volume of DOR; 
(5) M.tb+SD+DOR, M.tb‑infected macrophages were maintained 
in RPMI1640 culture medium containing 6 μM SD and 1 μM DOR 
for 6 days. Data are shown as the mean ± SD of 4 independent 
experiments carried out from 6 parallel infections. ★P < 0.05 versus 
M.tb + SD group
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polyvinylidene difluoride; Co‑IP: co‑immunoprecipitation; DOR: dorsomorphin; 
PI3 K: phosphoinositide 3‑kinase.
Authors’ contributions
XD the corresponding author, designed research and participated in its 
coordination. JZ carried out the co‑IP, western blot studies and participated in 
drafting the manuscript. QL carried out the confocal microscopy analysis. XZ 
participated in the cell culture and M.tb infection. RX performed the statistical 
analysis. All authors were involved in data interpretation and the writing of the 
paper. All authors read and approved the final manuscript.
Author details
1 Department of Respiratory Medicine, The First Affiliated Hospital of Chong‑
qing Medical University, Yu‑zhong District, Chongqing 400016, China. 
2 Department of Respiratory Medicine, The Second Affiliated Hospital, 
Chongqing Medical University, No.74 Linjiang Road, Yu‑zhong District, Chong‑
qing 400010, China. 3 Department of Respiratory Medicine, the First Affiliated 
Hospital of Hainan Medical University, Haikou, Hainan province 570102, China. 
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets supporting the conclusions of this article is presented in the 
main paper.
Ethics approval and consent to participate
This article did not contain any studies with human participants or animals 
performed by any of the authors.
Funding
This work was supported by grant from the National Nature Science Founda‑
tion of China (Grant number: 30872261 and 81500015), and Medical research 
plan of Chongqing Health and Family Planning Commission (Grant number: 
2015ZDXM013).
Received: 15 November 2016   Accepted: 20 December 2016
References
Akhtar N, Syed DN, Khan MI, Adhami VM, Mirza B, Mukhtar H (2016) The penta‑
cyclic triterpenoid, plectranthoic acid, a novel activator of AMPK induces 
apoptotic death in prostate cancer cells. Oncotarget 7:3819–3831. 
doi:10.18632/oncotarget.6625
Akihisa T, Franzblau SG, Ukiya M, Okuda H, Zhang F, Yasukawa K, Suzuki T, 
Kimura Y (2005) Antitubercular activity of triterpenoids from Asteraceae 
flowers. Biol Pharm Bull 28:158–160
Castro‑Garza J, Swords WE, Karls RK, Quinn FD (2012) Dual mechanism for 
Mycobacterium tuberculosis cytotoxicity on lung epithelial cells. Can J 
Microbiol 58:909–916. doi:10.1139/w2012‑067
Chua J, Deretic V (2004) Mycobacterium tuberculosis reprograms waves of 
phosphatidylinositol 3‑phosphate on phagosomal organelles. J Biol 
Chem 279:36982–36992. doi:10.1074/jbc.M405082200
Ejim L, Farha MA, Falconer SB, Wildenhain J, Coombes BK, Tyers M, Brown ED, 
Wright GD (2011) Combinations of antibiotics and nonantibiotic drugs 
enhance antimicrobial efficacy. Nat Chem Biol 7:348–350. doi:10.1038/
nchembio.559
Flannagan RS, Jaumouille V, Grinstein S (2012) The cell biology of phagocyto‑
sis. Annu Rev Pathol 7:61–98. doi:10.1146/annurev‑pathol‑011811‑132445
Fratti RA, Backer JM, Gruenberg J, Corvera S, Deretic V (2001) Role of phos‑
phatidylinositol 3‑kinase and Rab5 effectors in phagosomal biogenesis 
and mycobacterial phagosome maturation arrest. J Cell Biol 154:631–644. 
doi:10.1083/jcb.200106049
Fratti RA, Chua J, Deretic V (2003a) Induction of p38 mitogen‑activated protein 
kinase reduces early endosome autoantigen 1 (EEA1) recruitment to 
phagosomal membranes. J Biol Chem 278:46961–46967. doi:10.1074/jbc.
M305225200
Fratti RA, Chua J, Vergne I, Deretic V (2003b) Mycobacterium tuberculosis glyco‑
sylated phosphatidylinositol causes phagosome maturation arrest. Proc 
Natl Acad Sci USA 100:5437–5442. doi:10.1073/pnas.0737613100
Jyoti MA, Zerin T, Kim TH, Hwang TS, Jang WS, Nam KW, Song HY (2015) In vitro 
effect of ursolic acid on the inhibition of Mycobacterium tuberculosis and 
its cell wall mycolic acid. Pulm Pharmacol Ther 33:17–24. doi:10.1016/j.
pupt.2015.05.005
Lamb CA, Yoshimori T, Tooze SA (2013) The autophagosome: origins unknown, 
biogenesis complex. Nat Rev Mol Cell Biol 14:759–774. doi:10.1038/
nrm3696
Maxmen A (2013) Ahead of WHO meeting, experts clash over tuberculosis 
targets. Nat Med 19:115. doi:10.1038/nm0213‑115
Park JH, Kwak JH, Khoo JH, Park SH, Kim DU, Ha DM, Choi SU, Kang SC, Zee OP 
(2010) Cytotoxic effects of triterpenoid saponins from Androsace umbel-
lata against multidrug resistance (MDR) and non‑MDR cells. Arch Pharm 
Res 33:1175–1180. doi:10.1007/s12272‑010‑0807‑z
Purdy GE, Owens RM, Bennett L, Russell DG, Butcher BA (2005) Kinet‑
ics of phosphatidylinositol‑3‑phosphate acquisition differ 
between IgG bead‑containing phagosomes and Mycobacterium 
tuberculosis‑containing phagosomes. Cell Microbiol 7:1627–1634. 
doi:10.1111/j.1462‑5822.2005.00580.x
Rampini SK, Selchow P, Keller C, Ehlers S, Bottger EC, Sander P (2008) LspA 
inactivation in Mycobacterium tuberculosis results in attenuation without 
affecting phagosome maturation arrest. Microbiology 154:2991–3001. 
doi:10.1099/mic.0.2008/018895‑0
Rohde K, Yates RM, Purdy GE, Russell DG (2007) Mycobacterium tuberculosis 
and the environment within the phagosome. Immunol Rev 219:37–54. 
doi:10.1111/j.1600‑065X.2007.00547.x
Russell DG (2003) Phagosomes, fatty acids and tuberculosis. Nat Cell Biol 
5:776–778. doi:10.1038/ncb0903‑776
Russell DG (2011) Mycobacterium tuberculosis and the intimate dis‑
course of a chronic infection. Immunol Rev 240:252–268. 
doi:10.1111/j.1600‑065X.2010.00984.x
Russell RC, Tian Y, Yuan H, Park HW, Chang YY, Kim J, Kim H, Neufeld TP, Dillin 
A, Guan KL (2013) ULK1 induces autophagy by phosphorylating Beclin‑1 
and activating VPS34 lipid kinase. Nat Cell Biol 15:741–750. doi:10.1038/
ncb2757
Shi JM, Bai LL, Zhang DM, Yiu A, Yin ZQ, Han WL, Liu JS, Li Y, Fu DY, Ye WC 
(2013) Saxifragifolin D induces the interplay between apoptosis and 
autophagy in breast cancer cells through ROS‑dependent endoplas‑
mic reticulum stress. Biochem Pharmacol 85:913–926. doi:10.1016/j.
bcp.2013.01.009
Stokes RW, Haidl ID, Jefferies WA, Speert DP (1993) Mycobacteria‑macrophage 
interactions. Macrophage phenotype determines the nonopsonic bind‑
ing of Mycobacterium tuberculosis to murine macrophages. J Immunol 
151:7067–7076
Sun Q, Zhang J, Fan W, Wong KN, Ding X, Chen S, Zhong Q (2011) The RUN 
domain of rubicon is important for hVps34 binding, lipid kinase inhibi‑
tion, and autophagy suppression. J Biol Chem 286:185–191. doi:10.1074/
jbc.M110.126425
Vergne I, Chua J, Singh SB, Deretic V (2004) Cell biology of mycobacterium 
tuberculosis phagosome. Annu Rev Cell Dev Biol 20:367–394. doi:10.1146/
annurev.cellbio.20.010403.114015
Via LE, Deretic D, Ulmer RJ, Hibler NS, Huber LA, Deretic V (1997) Arrest of 
mycobacterial phagosome maturation is caused by a block in vesicle 
fusion between stages controlled by rab5 and rab7. J Biol Chem 
272:13326–13331
von Bargen K, Polidori M, Becken U, Huth G, Prescott JF, Haas A (2009) 
Rhodococcus equi virulence‑associated protein A is required for diver‑
sion of phagosome biogenesis but not for cytotoxicity. Infect Immun 
77:5676–5681. doi:10.1128/IAI.00856‑09
Wang Y, Zhang D, Ye W, Yin Z, Fung KP, Zhao S, Yao X (2008) Triterpenoid 
saponins from Androsace umbellata and their anti‑proliferative activi‑
ties in human hepatoma cells. Planta Med 74:1280–1284. doi:10.105
5/s‑2008‑1081291
Page 8 of 8Zhou et al. AMB Expr  (2017) 7:11 
Xu DQ, Wang Z, Wang CY, Zhang DY, Wan HD, Zhao ZL, Gu J, Zhang YX, Li ZG, 
Man KY, Pan Y, Wang ZF, Ke ZJ, Liu ZX, Liao LJ, Chen Y (2016) PAQR3 con‑
trols autophagy by integrating AMPK signaling to enhance ATG14L‑asso‑
ciated PI3K activity. EMBO J 35:496–514. doi:10.15252/embj.201592864
Yang CS, Kim JJ, Lee HM, Jin HS, Lee SH, Park JH, Kim SJ, Kim JM, Han YM, Lee 
MS, Kweon GR, Shong M, Jo EK (2014) The AMPK‑PPARGC1A pathway is 
required for antimicrobial host defense through activation of autophagy. 
Autophagy 10:785–802. doi:10.4161/auto.28072
Zhong Y, Wang QJ, Li X, Yan Y, Backer JM, Chait BT, Heintz N, Yue Z (2009) 
Distinct regulation of autophagic activity by Atg14L and Rubicon associ‑
ated with Beclin 1‑phosphatidylinositol‑3‑kinase complex. Nat Cell Biol 
11:468–476. doi:10.1038/ncb1854
Zumla A, Nahid P, Cole ST (2013) Advances in the development of new tuber‑
culosis drugs and treatment regimens. Nat Rev Drug Discov 12:388–404. 
doi:10.1038/nrd4001
